Biblio

Export 1937 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
C. Babiloni, Noce, G., Di Bonaventura, C., Lizio, R., Eldellaa, A., Tucci, F., Salamone, E. M., Ferri, R., Soricelli, A., Nobili, F., Famá, F., Arnaldi, D., Palma, E., Cifelli, P., Marizzoni, M., Stocchi, F., Bruno, G., Di Gennaro, G., Frisoni, G. B., and Del Percio, C., “Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 903-931, 2022.
C. Babiloni, Noce, G., Di Bonaventura, C., Lizio, R., Eldellaa, A., Tucci, F., Salamone, E. M., Ferri, R., Soricelli, A., Nobili, F., Famá, F., Arnaldi, D., Palma, E., Cifelli, P., Marizzoni, M., Stocchi, F., Bruno, G., Di Gennaro, G., Frisoni, G. B., and Del Percio, C., “Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 903-931, 2022.
M. Edsbagge, Andreasson, U., Ambarki, K., Wikkelsø, C., Eklund, A., Blennow, K., Zetterberg, H., and Tullberg, M., “Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.”, J Alzheimers Dis, vol. 58, no. 3, pp. 821-828, 2017.
U. Haditsch, Roth, T., Rodriguez, L., Hancock, S., Cecere, T., Nguyen, M., Arastu-Kapur, S., Broce, S., Raha, D., Lynch, C. C., Holsinger, L. J., Dominy, S. S., and Ermini, F., “Alzheimer's Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1361-1376, 2020.
D. Barthold, Gibbons, L. E., Marcum, Z. A., Gray, S. L., C Keene, D., Grabowski, T. J., Postupna, N., Larson, E. B., and Crane, P. K., “Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1303-1312, 2021.
E. Wang, Zhu, H., Wang, X., Gower, A., Wallack, M., Blusztajn, J. Krzysztof, Kowall, N., and Qiu, W. Qiao, “Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
T. M. Baran and Lin, F. Vankee, “Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.”, J Alzheimers Dis, vol. 66, no. 1, pp. 307-318, 2018.
C. - H. Yun, Lee, H. - Y., Lee, S. Ku, Kim, H., Seo, H. Suk, Bang, S. Ae, Kim, S. Eun, Greve, D. N., Au, R., Shin, C., and Thomas, R. J., “Amyloid Burden in Obstructive Sleep Apnea.”, J Alzheimers Dis, vol. 59, no. 1, pp. 21-29, 2017.
P. F. Høilund-Carlsen, Barrio, J. R., Werner, T. J., Newberg, A., and Alavi, A., “Amyloid Hypothesis: The Emperor's New Clothes?”, J Alzheimers Dis, vol. 78, no. 4, pp. 1363-1366, 2020.
G. Rolfseng Grøntvedt, Lauridsen, C., Berge, G., White, L. R., Salvesen, Ø., Bråthen, G., and Sando, S. Botne, “The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.”, J Alzheimers Dis, vol. 74, no. 3, pp. 829-837, 2020.
G. Rolfseng Grøntvedt, Lauridsen, C., Berge, G., White, L. R., Salvesen, Ø., Bråthen, G., and Sando, S. Botne, “The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.”, J Alzheimers Dis, vol. 74, no. 3, pp. 829-837, 2020.
A. Tiiman, Jelic, V., Jarvet, J., Järemo, P., Bogdanovic, N., Rigler, R., Terenius, L., Gräslund, A., and Vukojević, V., “Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.”, J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
D. D. Quintana, Garcia, J. A., Anantula, Y., Rellick, S. L., Engler-Chiurazzi, E. B., Sarkar, S. N., Brown, C. M., and Simpkins, J. W., “Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.”, J Alzheimers Dis, vol. 75, no. 1, pp. 119-138, 2020.
T. Daly, Houot, M., Barberousse, A., Agid, Y., and Epelbaum, S., “Amyloid-β in Alzheimer's Disease: A Study of Citation Practices of the Amyloid Cascade Hypothesis Between 1992 and 2019.”, J Alzheimers Dis, vol. 74, no. 4, pp. 1309-1317, 2020.
A. V. Morozov, Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen'ev, M. B., Sharova, N. P., Karpov, V. L., and Makarov, A. A., “Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.”, J Alzheimers Dis, vol. 54, no. 2, pp. 763-76, 2016.
E. N. Cline, Bicca, M. Assunção, Viola, K. L., and Klein, W. L., “The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.”, J Alzheimers Dis, vol. 64, no. s1, pp. S567-S610, 2018.
P. H. Nguyen, Del Castillo-Frias, M. P., Berthoumieux, O., Faller, P., Doig, A. J., and Derreumaux, P., “Amyloid-β/Drug Interactions from Computer Simulations and Cell-Based Assays.”, J Alzheimers Dis, vol. 64, no. s1, pp. S659-S672, 2018.
M. Jeong Wang, Yi, S. H., Han, J. - Y., Park, S. Young, Jang, J. - W., Chun, I. Kook, Van Giau, V., Bagyinszky, E., Lim, K. Taek, Kang, S. Min, An, S. Soo A., Park, Y. Ho, Youn, Y. Chul, and Kim, S. Y., “Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1403-13, 2016.
B. K. Binukumar, Shukla, V., Amin, N. D., Bhaskar, M., Skuntz, S., Steiner, J., Winkler, D., Pelech, S. L., and Pant, H. C., “Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.”, J Alzheimers Dis, 2015.
B. K. Binukumar, Shukla, V., Amin, N. D., Bhaskar, M., Skuntz, S., Steiner, J., Winkler, D., Pelech, S. L., and Pant, H. C., “Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.”, J Alzheimers Dis, 2015.
B. A. Ardekani, Convit, A., and Bachman, A. H., “Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 847-57, 2016.
M. Dlugaj, Winkler, A., Weimar, C., Dürig, J., Broecker-Preuss, M., Dragano, N., Moebus, S., Jöckel, K. - H., Erbel, R., and Eisele, L., “Anemia and Mild Cognitive Impairment in the German General Population.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
C. Weimar, Winkler, A., Dlugaj, M., Lehmann, N., Hennig, F., Bauer, M., Kröger, K., Kälsch, H., Mahabadi, A. - A., Dragano, N., Moebus, S., Hoffmann, B., Jöckel, K. - H., and Erbel, R., “Ankle-Brachial Index but Neither Intima Media Thickness Nor Coronary Artery Calcification is Associated With Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 47, no. 2, pp. 433-42, 2015.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., “ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.”, J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
T. G. Beach, Maarouf, C. L., Intorcia, A., Sue, L. I., Serrano, G. E., Lu, M., Joshi, A., Pontecorvo, M. J., and Roher, A. E., “Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1509-1516, 2018.

Pages